CAS: 50847-11-5; 1-(2-Isopropylpyrazolo[1,5-A]Pyridin-3-yl)-2-Methylpropan-1-One

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号7583-90-6 1-氨基-2-甲基吡啶碘化物 | CAS号97-72-3 异丁酸酐 | CAS号126959-38-4 2-异丙基吡唑并[1,5-a]... | CAS号101162-39-4 2-(2-hydroxy-1-... | CAS号79-31-2 异丁酸 | CAS号94144-52-2 1-(2-Isopropylp... | CAS号115619-23-3 3-(1-chloro-2-m... | CAS号59942-92-6 2-Isopropylpyra...

合成工艺路线路线简述

    1-氨基-2-甲基吡啶碘化物,异丁酸酐置于potassium Carbonate体系中,用 水,乙酸乙酯 作为反应溶剂,化学反应 9.0H,以51.3%的收率获得产物异丁司特
    参考文献:Wo2007/146087
    标题:Wo2007/146087

    海关参考信息

    专利信息


    专利号:US-9315483-B2
    优先权日:2007-09-13
    标题 :Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof
    发明人:JONES ANDREW D; ZELLE ROBERT E; SILVERMAN I ROBERT
    权利人:CONCERT PHARMACEUTICALS INC
    摘要:The present invention provides a convenient and efficient process for the synthesis of d 2 -benzo[d][1,3]dioxoles.

    专利号:WO-2017072796-A1
    优先权日:2015-10-30
    标题 :2-pyridone based compounds useful as potential phosphodiesterase3a (pde3a)inhibitors and a process for the preparation thereof
    发明人:KUMAR G JAGADEESH; MAHENDAR B; SAIDULU M; BANERJEE S K; RAO V JAYATHIRTHA
    权利人:COUNCIL SCIENT IND RES
    摘要:Formula A wherein X = COOCH 3 , COOC 2 H 5 , CN Y = Methyl, Phenyl R = alkyl, substituted phenyl, napthyl, furonyl, thiophenyl, substituted quinolinyl The present invention related to compounds of general FormulaA. The invention provides the synthesis of 2-pyridones useful as potential cardio tonic agents and a process for the preparation thereof.

    专利号:US-2015283095-A1
    优先权日:2012-11-16
    标 题:Nanoparticles with biodegradable and biocompatible polymer plga, loaded with the drug for human use pentoxifylline
    发明人:CONSTANDIL CÓRDOVA LUIS ERNERTO; IBARRA DURÃ?N PAULA SOLEDAD; VILOS ORTIZ CRISTIAN ANDRES; VELÃ?SQUEZ CUMPLIDO LUIS; PELISSIER SERRANO TERESA; LAURIDO FUENZALIDA CLAUDIO AURELIO; HERNÃ?NDEZ KUNSTMANN ALEJANDRO
    权利人:UNIV SANTIAGO CHILE
    摘要:The invention relates to a novel pharmaceutical formulation comprising polymer nanoparticles of the biodegradable and biocompatible polymer poly(lactic-glycolic) acid (PLGA), loaded with the drug pentoxifylline, the method for the synthesis of the PLGA nanoparticles loaded with pentoxifylline, and to the use thereof in the effective treatment for the relief of chronic pain and for the prevention of chronic pain via the administration of a single dose.

    专利号:WO-2009035652-A1
    优先权日:2007-09-13
    标 题 :Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof

    专利号:US-10335382-B2
    优先权日:2013-06-14
    标 题:Use of hydrogen sulfide synthesis inhibitors for cancer therapy
    发明人:HELLMICH MARK; ZHOU JIA; SZABO CSABA
    权利人:HELLMICH MARK; ZHOU JIA; SZABO CSABA; UNIV TEXAS
    摘要:In certain aspects the methods comprise administering an inhibitor of hydrogen sulfide biosynthesis, a cystathionine-β-synthase (CBS) inhibitor, or a hydrogen sulfide neutralizing agent to a patient having a cancer associated with elevated production of hydrogen sulfide.

    专利号:US-9751877-B2
    优先权日:2012-09-21
    标题 :Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
    发明人:PETTERSSON MARTIN YOUNGJIN; JOHNSON DOUGLAS SCOTT; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; AM ENDE CHRISTOPHER WILLIAM; GREEN MICHAEL ERIC; PATEL NANDINI CHATURBHAI; STIFF CORY MICHAEL; TRAN TUAN PHONG; KAUFFMAN GREGORY WAYNE; STEPAN ANTONIA FRIEDERIKE; VERHOEST PATRICK ROBERT
    权利人:PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    济南久隆医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jiulongjn.com
    企业联系电话:18560096895👤
    📞济南久隆医药科技有限公司 ⚠️参考联系方式
    联系人:闫经理
    电话:18560096895
    手机:18560096895

    邮箱:18560096895@163.com
    通信地址: 山东省济南市高新区春兰路1177号银丰国际生物城B7栋02号
    邮编: 250000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:山东省济南市高新区春兰路1177号银丰国际生物城B7栋02号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    济南共创医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sdgcpharm.com
    企业联系电话:0531-88065293-13287783460👤
    📞济南共创医药科技有限公司 ⚠️参考联系方式
    联系人:周经理
    电话:0531-88065293-13287783460
    手机:13287783460
    传真:0531-88065293
    邮箱:3166282224@qq.com
    通信地址: 山东 济南高新区世纪大道2966号
    邮编: 250100
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:山东 济南高新区世纪大道2966号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Johnson JL, Kwok YH, Sumracki NM, Swift JE, Hutchinson MR, Johnson K, Williams DB, Tuke J, Rolan PE. Glial Attenuation With Ibudilast in the Treatment of Medication Overuse Headache: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial of Efficacy and Safety. Headache. 2015 Oct;55(9):1192-208. doi: 10.1111/head.12655. Epub 2015 Sep 14.
    3: Charntikov S, Pittenger ST, Thapa I, Bastola DR, Bevins RA, Pendyala G. Ibudilast reverses the decrease in the synaptic signaling protein phosphatidylethanolamine-binding protein 1 (PEBP1) produced by chronic methamphetamine intake in rats. Drug Alcohol Depend. 2015 Jul 1;152:15-23. doi: 10.1016/j.drugalcdep.2015.04.012. Epub 2015 Apr 30. doi: 10.1016/j.pbb.2014.07.006. Epub 2014 Jul 17. doi: 10.1097/QAD.0000000000000291.
    6: Ellis A, Wieseler J, Favret J, Johnson KW, Rice KC, Maier SF, Falci S, Watkins LR. Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain. J Pain. 2014 Apr;15(4):407-21. doi: 10.1016/j.jpain.2013.12.007. Epub 2014 Jan 9.

    合成参考文献


    参考文献:10.1007/s00467-021-05199-1
    摘要:Trimarchi H. Crescents in primary glomerulonephritis: a pattern of injury with dissimilar actors. A pathophysiologic perspective. Pediatr Nephrol. 2022 Jun;37(6):1205–14. doi: 10.1007/s00467-021-05199-1.
    参考文献:10.1007/s40265-022-01689-0
    摘要:Sisignano M, Gribbon P, Geisslinger G. Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain. Drugs. 2022 Mar 07;82(4):357–73. doi: 10.1007/s40265-022-01689-0.
    参考文献:10.1007/s11060-005-9025-9
    摘要:Wu ZM, Yuan XH, Jiang PC, Li ZQ, Wu T. Antisense oligonucleodes targeting the focal adhesion kinase inhibit proliferation, induce apoptosis and cooperate with cytotoxic drugs in human glioma cells. J Neurooncol. 2006 Apr;77(2):117–23. doi: 10.1007/s11060-005-9025-9.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知